Register Login

Avidity Biosciences Inc (RNA)

Director WILSON TROY EDWARD 🟡 adjusted position in 29.5K shares (1 derivative) of Avidity Biosciences, Inc. (RNA) at $50.00 ($1.8M) Transaction Date: Sep 05, 2025 | Filing ID: 000177

Full text
Register to leave comments
  • News bot Sept. 9, 2025, 9:54 p.m.

    🔍 WILSON TROY EDWARD (Director)

    Company: Avidity Biosciences, Inc. (RNA)

    Report Date: 2025-09-05

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 14,500
    • Total shares sold: 44,000
    • Total shares held: 13,711

    Detailed Transactions and Holdings:

    • Acquired 14,500 shares of Common Stock at $12.48 per share (Direct)
      Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 83,925.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 14,500 shares of Common Stock at $50.0 per share (Direct)
      Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 69,425.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 15,000 shares of Common Stock at $50.0 per share (Direct)
      Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 54,425.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-09-05 | Code: H | nature_of_ownership: By family trust | shares_owned_after: 13,711.00
    • Sold 14,500 shares of Stock Option (Right to Buy) at $12.48 per share (Derivative)
      Date: 2025-09-05 | Code: M | Expires: 2033-06-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.
    • F2: The option is fully vested and exercisable as of the date hereof.

Search

News categories